Melting the eis: non-detection of kanamycin resistance markers by routine diagnostic tests and identification of new eis-promoter variants
Date Issued
2021-01-01
Author(s)
Pillay, S.
Streicher, E. M.
van der Heijden, Y. F.
Sirgel, F.
Derendinger, B.
de Kock, M.
Warren, R. M.
Theron, G.
de Vos, M.
DOI
10.1128/aac.02502-20
Abstract
Eis-promoter mutations can confer reduced Mycobacterium tuberculosis kanamycin susceptibility. GenoType MTBDRsl, a widely used assay evaluating this region, wrongly classified 17/410 isolates as eis-promoter wildtype. 6/17 isolates harbored mutations known to confer kanamycin resistance, and the remainder harbored either novel eis-promoter mutations (7/11) or disputed mutations (4/11). GenoType MTBDRsl can miss established and new variants that cause reduced susceptibility. These data highlight the importance of reflex phenotypic kanamycin testing.